BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 31376793)

  • 1. Oxidative inactivation of amyloid beta-degrading proteases by cholesterol-enhanced mitochondrial stress.
    de Dios C; Bartolessis I; Roca-Agujetas V; Barbero-Camps E; Mari M; Morales A; Colell A
    Redox Biol; 2019 Sep; 26():101283. PubMed ID: 31376793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol impairs autophagy-mediated clearance of amyloid beta while promoting its secretion.
    Barbero-Camps E; Roca-Agujetas V; Bartolessis I; de Dios C; Fernández-Checa JC; Marí M; Morales A; Hartmann T; Colell A
    Autophagy; 2018; 14(7):1129-1154. PubMed ID: 29862881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol alters mitophagy by impairing optineurin recruitment and lysosomal clearance in Alzheimer's disease.
    Roca-Agujetas V; Barbero-Camps E; de Dios C; Podlesniy P; Abadin X; Morales A; Marí M; Trullàs R; Colell A
    Mol Neurodegener; 2021 Mar; 16(1):15. PubMed ID: 33685483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial cholesterol loading exacerbates amyloid beta peptide-induced inflammation and neurotoxicity.
    Fernández A; Llacuna L; Fernández-Checa JC; Colell A
    J Neurosci; 2009 May; 29(20):6394-405. PubMed ID: 19458211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APP/PS1 mice overexpressing SREBP-2 exhibit combined Aβ accumulation and tau pathology underlying Alzheimer's disease.
    Barbero-Camps E; Fernández A; Martínez L; Fernández-Checa JC; Colell A
    Hum Mol Genet; 2013 Sep; 22(17):3460-76. PubMed ID: 23648430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GEPT extract reduces Abeta deposition by regulating the balance between production and degradation of Abeta in APPV717I transgenic mice.
    Tian J; Shi J; Zhang L; Yin J; Hu Q; Xu Y; Sheng S; Wang P; Ren Y; Wang R; Wang Y
    Curr Alzheimer Res; 2009 Apr; 6(2):118-31. PubMed ID: 19355846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
    Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O
    J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-signaling Pathway Regulates the Degradation of Amyloid β-protein via Astrocytes.
    Yamamoto N; Ishikuro R; Tanida M; Suzuki K; Ikeda-Matsuo Y; Sobue K
    Neuroscience; 2018 Aug; 385():227-236. PubMed ID: 29932983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simvastatin and atorvastatin facilitates amyloid β-protein degradation in extracellular spaces by increasing neprilysin secretion from astrocytes through activation of MAPK/Erk1/2 pathways.
    Yamamoto N; Fujii Y; Kasahara R; Tanida M; Ohora K; Ono Y; Suzuki K; Sobue K
    Glia; 2016 Jun; 64(6):952-62. PubMed ID: 26875818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of trichostatin A on gelsolin levels, proteolysis of amyloid precursor protein, and amyloid beta-protein load in the brain of transgenic mouse model of Alzheimer's disease.
    Yang W; Chauhan A; Wegiel J; Kuchna I; Gu F; Chauhan V
    Curr Alzheimer Res; 2014; 11(10):1002-11. PubMed ID: 25387339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CART modulates beta-amyloid metabolism-associated enzymes and attenuates memory deficits in APP/PS1 mice.
    Yin K; Jin J; Zhu X; Yu L; Wang S; Qian L; Han L; Xu Y
    Neurol Res; 2017 Oct; 39(10):885-894. PubMed ID: 28743230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracranial injection of AAV expressing NEP but not IDE reduces amyloid pathology in APP+PS1 transgenic mice.
    Carty N; Nash KR; Brownlow M; Cruite D; Wilcock D; Selenica ML; Lee DC; Gordon MN; Morgan D
    PLoS One; 2013; 8(3):e59626. PubMed ID: 23555730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced amyloid-β degradation in early Alzheimer's disease but not in the APPswePS1dE9 and 3xTg-AD mouse models.
    Stargardt A; Gillis J; Kamphuis W; Wiemhoefer A; Kooijman L; Raspe M; Benckhuijsen W; Drijfhout JW; Hol EM; Reits E
    Aging Cell; 2013 Jun; 12(3):499-507. PubMed ID: 23534431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondria, cholesterol and amyloid beta peptide: a dangerous trio in Alzheimer disease.
    Colell A; Fernández A; Fernández-Checa JC
    J Bioenerg Biomembr; 2009 Oct; 41(5):417-23. PubMed ID: 19784764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
    Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
    J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigallocatechin gallate induces extracellular degradation of amyloid β-protein by increasing neprilysin secretion from astrocytes through activation of ERK and PI3K pathways.
    Yamamoto N; Shibata M; Ishikuro R; Tanida M; Taniguchi Y; Ikeda-Matsuo Y; Sobue K
    Neuroscience; 2017 Oct; 362():70-78. PubMed ID: 28844000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Presymptomatic Changes in the Proteome of Mitochondria-Associated Membrane in the APP/PS1 Mouse Model of Alzheimer's Disease.
    Völgyi K; Badics K; Sialana FJ; Gulyássy P; Udvari EB; Kis V; Drahos L; Lubec G; Kékesi KA; Juhász G
    Mol Neurobiol; 2018 Oct; 55(10):7839-7857. PubMed ID: 29468564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders.
    Caccamo A; Oddo S; Sugarman MC; Akbari Y; LaFerla FM
    Neurobiol Aging; 2005 May; 26(5):645-54. PubMed ID: 15708439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Ageing and Oxidative Stress in Regulation of Amyloid-Degrading Enzymes and Development of Neurodegeneration.
    Nalivaeva NN; Turner AJ
    Curr Aging Sci; 2017; 10(1):32-40. PubMed ID: 27834125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-O-methylhonokiol attenuated memory impairment through modulation of oxidative damage of enzymes involving amyloid-β generation and accumulation in a mouse model of Alzheimer's disease.
    Choi IS; Lee YJ; Choi DY; Lee YK; Lee YH; Kim KH; Kim YH; Jeon YH; Kim EH; Han SB; Jung JK; Yun YP; Oh KW; Hwang DY; Hong JT
    J Alzheimers Dis; 2011; 27(1):127-41. PubMed ID: 21799245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.